O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N3-((2S)-4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-D-STREPTAMINE
UNII 969DC364WM
Substance Identification & Data
This profile provides standardized clinical and technical data for O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-n3-((2s)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-d-streptamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 969DC364WM.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 50725-24-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H43N5O13 OTDUEYVCDKBDRQ-PVLUVTDWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-n3-((2s)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-d-streptamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.